This is only compatible with IE 8 and later, so browse at your own risk or upgrade.Internet Explorer: IE8 以 推 奨 そ れ 以前 ブ ウ ザ を ご 使用 方 は 最 版 に プ グ て く だ さ。
M / CLOUDED
MANILA – The Philippines on Monday presented nine-month clinical trials in Avigan on the efficacy of the Japanese flu drug against the disease caused by the new coronavirus.
Undersecretary of Health Maria Rosario Vergeire said clinical trials will focus first on only 4 hospitals in the Metropolitan Manila area, but will include more in the future.
“The list of hospitals will be expanded so that we can have the hundred patients who will get the drugs assigned from the Japanese government,” Vergeire said at a press conference, adding that they had enough stock of the drug.
Avigan is the logo of favipiravir, an antiviral drug manufactured through a subsidiary of Fujifilm Holdings Corp.Japan, which is considered a possible remedy for COVID-19, a respiratory disease caused by the new coronavirus.
Avigan’s clinical trials will be an “open, multicenter, randomized comparative arrangement,” Vergeire said last week, with participants divided into two groups.
The first patient organization will get existing supportive care in hospitals.At that time the organization will get them in addition to being administered with the drug.
The Filipino official added that only others between the ages of 18 and 74 can participate in the trials and that they will need to be willing to use contraceptives for the duration of the study.
Vergeire said contraceptives are because the drug is teratogenic, meaning it can only cause birth defects.
A total of 18 million pesos ($366,000) has been allocated through the Philippines for clinical trials.
Fujifilm Holdings said last Thursday that it planned to conduct full Avigan trials in Japan in September and seek approval.
Prime Minister Shinzo Abe had expressed his hope earlier this year that Avigan would be approved in May, however, an interim report from a Japanese university, published that month, did not imply a transparent efficacy of the drug in the COVID-19 remedy.
In the Philippines, 164,474 cases of COVID-19 were recorded on Monday, 2,681 deaths.
Since the early stages of the COVID-19 crisis, the Japan Times has provided free access to very important data on the effect of the new coronavirus, as well as practical data on how to deal with the pandemic.Please note that you can subscribe today so that we can continue to provide you with up-to-date and detailed data about Japan.
The Japan Times LTD. All rights are reserved.